Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Johnson & Johnson pauses use of FDA-approved PFA system to investigate patient complications
Johnson & Johnson MedTech's Varipulse PFA system has been linked to multiple reports of "neurovascular events" in patients. The company hopes to share more information in the days ahead.
Stryker acquires Inari Medical for $4.9B
Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.
‘Fundamental for all patients’: Exploring the benefits of palliative care for stroke survivors
Approximately 800,000 strokes occur each year in the United States alone. A majority of people survive, due in part to key advances in patient care over the years, but they often go forward without receiving the long-term help they need to recover and thrive.
Advancing AI for vascular surgery will require a commitment to data integrity
For artificial intelligence to truly transform care, the healthcare industry must address certain challenges. Jens Eldrup-Jorgensen, MD, a veteran vascular surgeon and member of the Society for Vascular Surgery, explains in a guest editorial.
Industry concerns over paclitaxel-coated devices may have put PAD patients at risk
Back in 2019, the FDA issued a warning about the use of paclitaxel-coated devices when treating peripheral artery disease. The agency took back that warning in 2023, but it appears to have made a significant impact on patient care.

Stroke surgeons issue warning to public: Time is still brain during COVID-19 pandemic

The COVID-19 pandemic is changing patient care at hospitals all over the world, but a group of leading surgeons wants to make sure people aren’t ignoring stroke symptoms due to fears over getting the virus.

April 1, 2020

Cardiac injury in COVID-19 patients associated with higher in-hospital mortality

Cardiac injury is common among patients hospitalized with COVID-19, according to new research out of Wuhan, China. The study, published in JAMA Cardiology, also found that cardiac injuries were associated with an increased risk of in-hospital mortality.

March 25, 2020

Abdominal stent graft solution from Endologix gains FDA approval

Endologix, an Irvine, California-based healthcare technology company, has received FDA approval for its new abdominal stent graft solution.

March 19, 2020

Risk of death from stroke drops 24%

The primary reason behind this change is believed to be significant improvements in how healthcare providers care for stroke patients.

March 18, 2020

FDA updates warnings for cigarette packaging, advertisements—compliance required by June 2021

The FDA has published new requirements for the health warnings featured on cigarette packages and in cigarette advertisements.

March 17, 2020

Music therapy improves stroke survivors’ dexterity, mood

Music therapy can be a helpful neurorehabilitation tool for acute stroke patients on the mend, according to research published in Topics in Stroke Rehabilitation.

March 6, 2020

Some CV drugs increase exposure, psychoactive effects of THC

A host of prescription drugs—including warfarin and other CV medications—may have potential drug interactions with the THC and cannabidiol in marijuana, according to an article published in the Canadian Medical Association Journal.

March 4, 2020

Less than ⅕ of US stroke patients have timely access to thrombectomy

Just under 20% of Americans have rapid access to endovascular thrombectomy for stroke, according to a study out of the University of Texas Health Science Center at Houston.

March 3, 2020

Vascular & Endovascular

Johnson & Johnson pauses use of FDA-approved PFA system to investigate patient complications

Stryker acquires Inari Medical for $4.9B

‘Fundamental for all patients’: Exploring the benefits of palliative care for stroke survivors

Advancing AI for vascular surgery will require a commitment to data integrity

Industry concerns over paclitaxel-coated devices may have put PAD patients at risk